Essential thrombocythemia (ET) is an acquired myeloproliferative disorder (MPD)
characterized by a sustained elevation of platelet number with a tendency for thrombosis …

In polycythemia vera, vascular risk assessment is based on age and thrombotic history,
while the role of other potential predictors of this risk is still uncertain. Thus, we exploited the …

Extracts of several plants possess antithrombotic effects. Herein, we examined the
antithrombotic effects of different extracts of Artemisia princeps Pampanini prepared using …

Hintergrund: Polyzythaemia vera (PV) gehört zu den myeloproliferativen Erkrankungen und
ist durch vermehrte Erythropoese mit Hyperviskosität charakterisiert. Obwohl …

Background Patients with essential thrombocythemia (ET) and coronary artery disease
(CAD) have increased risk of thromboembolic complications. In addition, a reduced …

BACKGROUND: The aim of this study was to describe platelet aggregation characteristics
by multiple electrode aggregometry (MEA) and to evaluate MEA for its potential to detect …

Essential thrombocythemia (ET) is an acquired clonal hematological stem-cell disorder that
is characterized by a persistent increase in platelet count over 600,000/μl and elevated …

Interventions: PRES was treated with a dehydrating agent and supportive and symptomatic
treatments. Aspirin tablets were prescribed to address the patient's ET. Outcome: After …

Introduction: Two factors have deeply influenced the area of essential thrombocythemia
(ET). A gain-of-function mutation in the pseudokinase region of the JAK2 gene, which partly …

Myeloproliferative disorders (MPD) are associated with vascular thrombosis. Common sites
for thrombosis are large arteries; however, less commonly, cerebral venous sinus …